Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Chemin

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2019
Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in AfricaYusuke Shimakawa, Gibril Ndow, Ramou Njie, et al.
JHEP Reports : Innovation in Hepatology|September 2, 2022
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programmeAmina Sow, Maud Lemoine, Papa Souleymane Toure, et al.
Journal of Viral Hepatitis|March 22, 2021
Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis BGerrit Post, Jess Howell, Amina Sow, et al.
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2019
Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in AfricaYusuke Shimakawa, Gibril Ndow, Ramou Njie, et al.
JHEP Reports : Innovation in Hepatology|September 2, 2022
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programmeAmina Sow, Maud Lemoine, Papa Souleymane Toure, et al.
Journal of Viral Hepatitis|March 22, 2021
Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis BGerrit Post, Jess Howell, Amina Sow, et al.
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
Hepatitis Research and Treatment|November 25, 2011
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from ColombiaMaria-Cristina Navas, Iris Suarez, Andrea Carreño, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
Pageof 8